Andrea Lobo,  —

Articles by Andrea Lobo

Phase 1b trial of STAR-LLD combo for myeloma approved by FDA

The U.S. Food and Drug Administration (FDA) has cleared the launch of a Phase 1b trial to test STAR-LLD, Starton Therapeutics’ experimental continuous delivery of low-dose lenalidomide into the blood, in people with multiple myeloma. The U.S.-based study, expected to start in the last months of the year,…